{"transactions":[{"id":731837,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T23:05:16.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":31566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":31566,"derivative":{"exercise_price":3.03,"expiration_date":"2036-06-15","underlying":"Common stock","underlying_shares":31566},"source":{"system":"sec-edgar","filing":"0001493152-26-029416","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226029416/ownership.xml","form_type":"4"}},{"id":731836,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T23:05:16.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":28409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":501193,"source":{"system":"sec-edgar","filing":"0001493152-26-029416","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226029416/ownership.xml","form_type":"4"}},{"id":754339,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-03T00:35:01.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":2.9801,"value":29801.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.9801, and the range of prices were between $2.94 and $3.05. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":472784,"source":{"system":"sec-edgar","filing":"0001493152-26-026930","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226026930/ownership.xml","form_type":"4"}},{"id":865980,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-04T01:05:01.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":2.8957,"value":28957.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.8957, and the range of prices were between $2.82 and $3.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":482784,"source":{"system":"sec-edgar","filing":"0001493152-26-008743","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226008743/ownership.xml","form_type":"4"}},{"id":983353,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T00:00:26.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":5.0008,"value":50008.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $5.0008, and the range of prices were between $4.73 and $5.34. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":492784,"source":{"system":"sec-edgar","filing":"0001493152-25-025811","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315225025811/ownership.xml","form_type":"4"}},{"id":1052722,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-29T20:30:58.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":28576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":28576,"derivative":{"exercise_price":3.64,"expiration_date":"2035-08-26","underlying":"Common stock","underlying_shares":28576},"source":{"system":"sec-edgar","filing":"0001641172-25-026003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026003/ownership.xml","form_type":"4"}},{"id":1052721,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-29T20:30:58.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":22283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":502784,"source":{"system":"sec-edgar","filing":"0001641172-25-026003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026003/ownership.xml","form_type":"4"}},{"id":1102533,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:10:04.000Z","date":"2025-06-06","kind":"gift","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":480501,"source":{"system":"sec-edgar","filing":"0001415889-25-018048","document":"form4-06242025_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588925018048/form4-06242025_040601.xml","form_type":"4"}},{"id":1319705,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Right to Buy)","published_at":"2024-12-31T18:20:10.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":50469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":50469,"derivative":{"exercise_price":1.96,"expiration_date":"2034-07-31","underlying":"Common Stock","underlying_shares":50469},"source":{"system":"sec-edgar","filing":"0001415889-24-030277","document":"form4a-12312024_011207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924030277/form4a-12312024_011207.xml","form_type":"4/A","original_submission_date":"2024-08-05"}},{"id":1440555,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Right to Buy)","published_at":"2024-08-05T22:35:55.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":50469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":50469,"derivative":{"exercise_price":1.54,"expiration_date":"2034-07-31","underlying":"Common Stock","underlying_shares":50469},"source":{"system":"sec-edgar","filing":"0001415889-24-020779","document":"form4-08052024_100850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924020779/form4-08052024_100850.xml","form_type":"4"}},{"id":1440554,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T22:35:55.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":39541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":505501,"source":{"system":"sec-edgar","filing":"0001415889-24-020779","document":"form4-08052024_100850.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924020779/form4-08052024_100850.xml","form_type":"4"}},{"id":1486435,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant (Right to Buy)","published_at":"2024-06-08T01:45:16.000Z","date":"2024-05-29","kind":"purchase","planned":false,"acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's purchase reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of common stock on December 13, 2023.  The Reporting Person has agreed to pay to the Issuer the profit realized in connection with the short-swing transaction, less transaction costs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities consist of shares of common stock sold together with accompanying warrants to purchase common stock.  The combined price of each share of common stock offered together with one warrant was $4.00."}],"balance_after":2500,"derivative":{"exercise_price":5.25,"exercise_date":"2024-05-29","expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001415889-24-016108","document":"form4-06072024_090608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924016108/form4-06072024_090608.xml","form_type":"4"}},{"id":1486434,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-08T01:45:16.000Z","date":"2024-05-29","kind":"purchase","planned":false,"acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's purchase reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of common stock on December 13, 2023.  The Reporting Person has agreed to pay to the Issuer the profit realized in connection with the short-swing transaction, less transaction costs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities consist of shares of common stock sold together with accompanying warrants to purchase common stock.  The combined price of each share of common stock offered together with one warrant was $4.00."}],"balance_after":465960,"source":{"system":"sec-edgar","filing":"0001415889-24-016108","document":"form4-06072024_090608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924016108/form4-06072024_090608.xml","form_type":"4"}},{"id":1710788,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-15T01:58:32.000Z","date":"2023-12-13","kind":"sale","planned":false,"acquired":false,"shares":1927,"price":13.9277,"value":26838.6779,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $13.9277, and the range of prices were between $13.80 and $14.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":463460,"source":{"system":"sec-edgar","filing":"0001209191-23-058709","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123058709/doc4.xml","form_type":"4"}},{"id":1710787,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-15T01:58:32.000Z","date":"2023-12-13","kind":"sale","planned":false,"acquired":false,"shares":7073,"price":13.2261,"value":93548.2053,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average sale price for the transaction reported was $13.2261, and the range of prices were between $12.76 and $13.75. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":465387,"source":{"system":"sec-edgar","filing":"0001209191-23-058709","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123058709/doc4.xml","form_type":"4"}},{"id":1759785,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T22:39:20.000Z","date":"2023-10-16","kind":"sale","planned":false,"acquired":false,"shares":881,"price":21.3037,"value":18768.5597,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $21.3037, and the range of prices were between $21.17 and $21.75. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":472460,"source":{"system":"sec-edgar","filing":"0001209191-23-052904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123052904/doc4.xml","form_type":"4"}},{"id":1759784,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T22:39:20.000Z","date":"2023-10-16","kind":"sale","planned":false,"acquired":false,"shares":2452,"price":20.5014,"value":50269.4328,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $20.5014, and the range of prices were between $20.10 and $20.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":473341,"source":{"system":"sec-edgar","filing":"0001209191-23-052904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123052904/doc4.xml","form_type":"4"}},{"id":1778725,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-19T00:12:03.000Z","date":"2023-09-18","kind":"sale","planned":false,"acquired":false,"shares":3334,"price":24.99,"value":83316.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2023."}],"balance_after":475793,"source":{"system":"sec-edgar","filing":"0001209191-23-049840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123049840/doc4.xml","form_type":"4"}},{"id":1778724,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-19T00:12:03.000Z","date":"2023-09-15","kind":"sale","planned":false,"acquired":false,"shares":1088,"price":22.3838,"value":24353.5744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $22.3838, and the range of prices were between $22.19 and $22.75. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":479127,"source":{"system":"sec-edgar","filing":"0001209191-23-049840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123049840/doc4.xml","form_type":"4"}},{"id":1778723,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-19T00:12:03.000Z","date":"2023-09-15","kind":"sale","planned":false,"acquired":false,"shares":2245,"price":21.667,"value":48642.415,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $21.667, and the range of prices were between $21.17 and $22.15. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":480215,"source":{"system":"sec-edgar","filing":"0001209191-23-049840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123049840/doc4.xml","form_type":"4"}},{"id":1781899,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-14T00:15:42.000Z","date":"2023-09-11","kind":"grant","planned":false,"acquired":true,"shares":4397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":4397,"derivative":{"exercise_price":22.4,"expiration_date":"2033-09-10","underlying":"Common Stock","underlying_shares":4397},"source":{"system":"sec-edgar","filing":"0001209191-23-049365","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123049365/doc4.xml","form_type":"4"}},{"id":1781898,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-14T00:15:42.000Z","date":"2023-09-11","kind":"grant","planned":false,"acquired":true,"shares":3460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan.  Each RSU represents the contingent right to receive one share of common stock upon vesting.  The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":482460,"source":{"system":"sec-edgar","filing":"0001209191-23-049365","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123049365/doc4.xml","form_type":"4"}},{"id":1908086,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-02T20:28:55.000Z","date":"2023-02-17","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan.  Each RSU represents the contingent right to receive one share of common stock upon vesting.  The RSUs will be fully vested on July 25, 2023."}],"balance_after":479000,"source":{"system":"sec-edgar","filing":"0001209191-23-026507","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123026507/doc4.xml","form_type":"4"}},{"id":2042010,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-01-30T21:28:05.000Z","date":"2023-01-30","kind":"exercise","acquired":false,"shares":1410000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":470000},"source":{"system":"sec-edgar","filing":"0001209191-23-005478","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123005478/doc4.xml","form_type":"4"}},{"id":2042009,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-30T21:28:05.000Z","date":"2023-01-30","kind":"exercise","acquired":true,"shares":470000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."}],"balance_after":470000,"source":{"system":"sec-edgar","filing":"0001209191-23-005478","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123005478/doc4.xml","form_type":"4"}}]}